CLB
Core Laboratories NV
11.30$
-1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -26.5% | -25.4% | +10.9% | +6.2% | -4.7% | -27.1% | -3.5% | +4.1% | +4.1% | +2.8% | +0.5% | |
| – | -19.1% | -16.2% | +6.3% | +4.2% | -4.7% | -22.3% | +0.3% | +6.3% | +1.2% | +4.7% | -0.7% | |
| – | -39.6% | -47.3% | +28.3% | +12.6% | -4.5% | -40.8% | -17.9% | -5.9% | +19.2% | -6.0% | +6.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.9% | -20.8% | +21.2% | +31.8% | -23.7% | -29.1% | +29.8% | -13.7% | +5.6% | -4.1% | +14.6% | |
| – | +8.9% | -20.8% | +21.2% | +31.8% | +20.7% | +135.6% | -78.4% | -3.1% | +5.4% | -24.3% | +46.9% | |
| – | -53.5% | -46.5% | +30.5% | +5.5% | -18.5% | -179.4% | – | -8.3% | +31.6% | +7.2% | -13.8% | |
| – | +16.8% | -6.5% | -7.2% | +24.2% | +10.2% | -2.2% | -36.3% | +26.4% | +16.1% | -7.9% | -14.5% | |
| – | -55.7% | -49.8% | +36.3% | +3.5% | -22.1% | -211.2% | – | -17.0% | +37.6% | +12.1% | -0.6% | |
| – | -56.3% | -68.2% | +73.1% | +36.7% | -148.3% | – | +169.5% | -35.2% | -59.4% | +235.3% | +10.5% | |
| – | -55.4% | -44.4% | +30.1% | -4.3% | +28.2% | -195.7% | – | -1.4% | +88.5% | -14.4% | -5.5% | |
| – | -49.5% | -40.0% | +19.0% | +5.4% | -12.1% | -43.4% | -9.5% | -8.0% | +20.0% | +4.4% | -3.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.